HIV-1 Molecular Biology and Pathogenesis

The following book volume has been published in January 2008; an accompanying book volume (volume 55 on basic HIV mechanisms) was released in October 2007. 

 HIV I: Molecular Biology and Pathogenesis: Clinical Applications, Volume 56, Second Edition (Advances in Pharmacology) (Advances in Pharmacology) (Hardcover)
by Kuan-Teh Jeang (Editor) containing the following 17 chapters (each of the chapters has been listed in PubMed with the indicated identification number)

1: Angeletti PC, Zhang L, Wood C.

 The viral etiology of AIDS-associated malignancies.

Adv Pharmacol. 2008;56:509-57. PMID: 18086422



2: Ahmad N.

 Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants. Adv Pharmacol. 2008;56:453-508. PMID: 18086421



3: Schiavone M, Quinto I, Scala G.

 Perspectives for a protective HIV-1 vaccine.

Adv Pharmacol. 2008;56:423-52. PMID: 18086420


 4: Hoang V, Withers-Ward E, Camerini D.

 Nonprimate models of HIV-1 infection and pathogenesis.

Adv Pharmacol. 2008;56:399-422. PMID: 18086419


 5: Dang Q, Hirsch VM.

 Rapid disease progression to AIDS due to Simian immunodeficiency virus infection of macaques: host and viral factors.

Adv Pharmacol. 2008;56:369-98. PMID: 18086418


 6: Klase ZA, Van Duyne R, Kashanchi F.

 Identification of potential drug targets using genomics and proteomics: a systems approach.

Adv Pharmacol. 2008;56:327-68. PMID: 18086417


 7: Giacca M.

 Gene therapy to induce cellular resistance to HIV-1 infection: lessons from clinical trials.

Adv Pharmacol. 2008;56:297-325. PMID: 18086416


 8: Quiñones-Mateu ME, Moore-Dudley DM, Jegede O, Weber J, J Arts E.

 Viral drug resistance and fitness.

Adv Pharmacol. 2008;56:257-96. PMID: 18086415


 9: Turpin JA, Schito ML, Jenkins LM, Inman JK, Appella E.

 Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors.

Adv Pharmacol. 2008;56:229-56. PMID: 18086414


 10: Semenova EA, Marchand C, Pommier Y.

 HIV-1 integrase inhibitors: update and perspectives.

Adv Pharmacol. 2008;56:199-228. PMID: 18086413


 11: Mitsuya H, Maeda K, Das D, Ghosh AK.  Development of protease inhibitors and the fight with drug-resistant HIV-1 variants. Adv Pharmacol. 2008;56:169-97.PMID: 18086412

 12: Ilina T, Parniak MA.

 Inhibitors of HIV-1 reverse transcriptase.

Adv Pharmacol. 2008;56:121-67. PMID: 18086411


 13: Strizki J.

 Targeting HIV attachment and entry for therapy.

Adv Pharmacol. 2008;56:93-120. PMID: 18086410


 14: Harari A, Pantaleo G.

 HIV-1-specific immune response.

Adv Pharmacol. 2008;56:75-92. PMID: 18086409


 15: Murphy EM, Jimenez HR, Smith SM.

 Current clinical treatments of AIDS.

Adv Pharmacol. 2008;56:27-73. PMID: 18086408


 16: Takebe Y, Uenishi R, Li X.

 Global molecular epidemiology of HIV: understanding the genesis of AIDS pandemic.

Adv Pharmacol. 2008;56:1-25. PMID: 18086407


17: Weiss RA.


Adv Pharmacol. 2008;56:XV-XVII. PMID: 18086406


View the latest posts on the On Biology homepage